BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21546556)

  • 1. DNA-dependent protein kinase and ataxia telangiectasia mutated (ATM) promote cell survival in response to NK314, a topoisomerase IIα inhibitor.
    Guo L; Liu X; Jiang Y; Nishikawa K; Plunkett W
    Mol Pharmacol; 2011 Aug; 80(2):321-7. PubMed ID: 21546556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of topoisomerase IIalpha and G2 cell cycle arrest by NK314, a novel benzo[c]phenanthridine currently in clinical trials.
    Guo L; Liu X; Nishikawa K; Plunkett W
    Mol Cancer Ther; 2007 May; 6(5):1501-8. PubMed ID: 17513599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK314, a topoisomerase II inhibitor that specifically targets the alpha isoform.
    Toyoda E; Kagaya S; Cowell IG; Kurosawa A; Kamoshita K; Nishikawa K; Iiizumi S; Koyama H; Austin CA; Adachi N
    J Biol Chem; 2008 Aug; 283(35):23711-20. PubMed ID: 18596031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK314 potentiates antitumor activity with adult T-cell leukemia-lymphoma cells by inhibition of dual targets on topoisomerase II{alpha} and DNA-dependent protein kinase.
    Hisatomi T; Sueoka-Aragane N; Sato A; Tomimasu R; Ide M; Kurimasa A; Okamoto K; Kimura S; Sueoka E
    Blood; 2011 Mar; 117(13):3575-84. PubMed ID: 21245486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK314, a novel topoisomerase II inhibitor, induces rapid DNA double-strand breaks and exhibits superior antitumor effects against tumors resistant to other topoisomerase II inhibitors.
    Onda T; Toyoda E; Miyazaki O; Seno C; Kagaya S; Okamoto K; Nishikawa K
    Cancer Lett; 2008 Jan; 259(1):99-110. PubMed ID: 17998154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK.
    Das BB; Antony S; Gupta S; Dexheimer TS; Redon CE; Garfield S; Shiloh Y; Pommier Y
    EMBO J; 2009 Dec; 28(23):3667-80. PubMed ID: 19851285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of poly (ADP-ribose) polymerase activates ATM which is required for subsequent homologous recombination repair.
    Bryant HE; Helleday T
    Nucleic Acids Res; 2006; 34(6):1685-91. PubMed ID: 16556909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription-dependent activation of ataxia telangiectasia mutated prevents DNA-dependent protein kinase-mediated cell death in response to topoisomerase I poison.
    Sakasai R; Teraoka H; Takagi M; Tibbetts RS
    J Biol Chem; 2010 May; 285(20):15201-15208. PubMed ID: 20304914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of DNA-PK potentiates the synergistic effect of NK314 and etoposide combination on human glioblastoma cells.
    Kopa P; Macieja A; Gulbas I; Pastwa E; Poplawski T
    Mol Biol Rep; 2020 Jan; 47(1):67-76. PubMed ID: 31583565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATM regulates ATR chromatin loading in response to DNA double-strand breaks.
    Cuadrado M; Martinez-Pastor B; Murga M; Toledo LI; Gutierrez-Martinez P; Lopez E; Fernandez-Capetillo O
    J Exp Med; 2006 Feb; 203(2):297-303. PubMed ID: 16461339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxia telangiectasia-mutated protein and DNA-dependent protein kinase have complementary V(D)J recombination functions.
    Zha S; Jiang W; Fujiwara Y; Patel H; Goff PH; Brush JW; Dubois RL; Alt FW
    Proc Natl Acad Sci U S A; 2011 Feb; 108(5):2028-33. PubMed ID: 21245310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revised genetic requirements for the decatenation G2 checkpoint: the role of ATM.
    Bower JJ; Zhou Y; Zhou T; Simpson DA; Arlander SJ; Paules RS; Cordeiro-Stone M; Kaufmann WK
    Cell Cycle; 2010 Apr; 9(8):1617-28. PubMed ID: 20372057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular signal-related kinase positively regulates ataxia telangiectasia mutated, homologous recombination repair, and the DNA damage response.
    Golding SE; Rosenberg E; Neill S; Dent P; Povirk LF; Valerie K
    Cancer Res; 2007 Feb; 67(3):1046-53. PubMed ID: 17283137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant V(D)J recombination in ataxia telangiectasia mutated-deficient lymphocytes is dependent on nonhomologous DNA end joining.
    Bredemeyer AL; Huang CY; Walker LM; Bassing CH; Sleckman BP
    J Immunol; 2008 Aug; 181(4):2620-5. PubMed ID: 18684952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live-cell tracking of γ-H2AX kinetics reveals the distinct modes of ATM and DNA-PK in the immediate response to DNA damage.
    Trakarnphornsombat W; Kimura H
    J Cell Sci; 2023 Apr; 136(8):. PubMed ID: 36999484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective Mre11-dependent activation of Chk2 by ataxia telangiectasia mutated in colorectal carcinoma cells in response to replication-dependent DNA double strand breaks.
    Takemura H; Rao VA; Sordet O; Furuta T; Miao ZH; Meng L; Zhang H; Pommier Y
    J Biol Chem; 2006 Oct; 281(41):30814-23. PubMed ID: 16905549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The catalytic topoisomerase II inhibitor dexrazoxane induces DNA breaks, ATF3 and the DNA damage response in cancer cells.
    Deng S; Yan T; Nikolova T; Fuhrmann D; Nemecek A; Gödtel-Armbrust U; Kaina B; Wojnowski L
    Br J Pharmacol; 2015 May; 172(9):2246-57. PubMed ID: 25521189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation.
    Stiff T; O'Driscoll M; Rief N; Iwabuchi K; Löbrich M; Jeggo PA
    Cancer Res; 2004 Apr; 64(7):2390-6. PubMed ID: 15059890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ataxia-telangiectasia-mutated-dependent activation of Ku in human fibroblasts exposed to hydrogen peroxide.
    Lee JH; Kim KH; Morio T; Kim H
    Ann N Y Acad Sci; 2006 Dec; 1091():76-82. PubMed ID: 17341604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique and redundant functions of ATM and DNA-PKcs during V(D)J recombination.
    Gapud EJ; Sleckman BP
    Cell Cycle; 2011 Jun; 10(12):1928-35. PubMed ID: 21673501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.